Clinical Trials Browser

OTHER × Metastatic Castration-resistant Prostate Cancer × Standard of Care × Clear all

NCT06401980 2026-03-30

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer